Hyunsoon Kang

1.1k citations

11 papers · 795 indexed · h-index 9

Co-authors: Isabel Nájera Sophie Le Pogam Julian Symons Nick Cammack Wen-Rong Jiang Sonal Rajyaguru Samir Ali Klaus Klumpp
Topics: Hepatitis C virus research (9 papers)Hepatitis B Virus Studies (8 papers)HIV/AIDS drug development and treatment (7 papers)
Cited by: Hepatology Infectious Diseases Virology
Journals: Journal of Biological Chemistry Journal of Virology The Journal of Infectious Diseases
Partner nations: United States Australia Italy

In The Last Decade

Hyunsoon Kang

11 papers receiving 746 citations

Peers

Countries citing papers authored by Hyunsoon Kang

Since Specialization

Citations

This map shows the geographic impact of Hyunsoon Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyunsoon Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyunsoon Kang more than expected).

Fields of papers citing papers by Hyunsoon Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyunsoon Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyunsoon Kang. The network helps show where Hyunsoon Kang may publish in the future.

Co-authorship network of co-authors of Hyunsoon Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyunsoon Kang. A scholar is included among the top collaborators of Hyunsoon Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyunsoon Kang. Hyunsoon Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	1222 IN VITRO RESISTANCE TO ALS-2200, A POTENT NUCLEOTIDE POLYMERASE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS C 2013 ·Journal of Hepatology ·Hui‐Leng Tan,Andreas Jekle,Hyunsoon Kang,(unknown),Jérôme Deval,Ann M. Tigges,(unknown),Min Jiang,(unknown),Natalia Dyatkina,(unknown),René Rijnbrand,Tara L. Kieffer,(unknown),Leo Beigelman,David B. Smith,Julian Symons	1
2	Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics upon Short-Term Dual Therapy with the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir 2012 ·Antimicrobial Agents and Chemotherapy ·Sophie Le Pogam,(unknown),M. B. Chhabra,Mariola Ilnicka,Hyunsoon Kang,Alan Kosaka,S ALI,Daniel J. Chin,Nancy S. Shulman,Patrick F. Smith,Klaus Klumpp,Isabel Nájera	25
3	RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients 2010 ·The Journal of Infectious Diseases ·Sophie Le Pogam,(unknown),(unknown),Hyunsoon Kang,Alan Kosaka,(unknown),M. Michelle Berrey,(unknown),Abel De La Rosa,Nick Cammack,Isabel Nájera	43
4	Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients 2008 ·Journal of Antimicrobial Chemotherapy ·Sophie Le Pogam,(unknown),Alan Kosaka,Stephan Chiu,Hyunsoon Kang,Song Hu,Sonal Rajyaguru,Julian Symons,(unknown),Isabel Nájera	106
5	The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors 2008 ·Antimicrobial Agents and Chemotherapy ·Matthew F. McCown,Sonal Rajyaguru,Sophie Le Pogam,Samir Ali,Wen-Rong Jiang,Hyunsoon Kang,Julian Symons,Nick Cammack,Isabel Nájera	132
6	851 ANTIVIRAL POTENCY OF R1479, ACTIVE COMPOUND DERIVED IN VIVO FROM PRODRUG R1626, DEMONSTRATED ACROSS HCV GENOTYPES 1-6 IN NS5B RECOMBINANT ENZYMES AND HCV REPLICONS 2008 ·Journal of Hepatology ·Vincent Lévêque,Sophie Le Pogam,Hyunsoon Kang,(unknown),Alan Kosaka,(unknown),Julian Symons,(unknown),Klaus Klumpp,Isabel Nájera	4
7	Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479 2008 ·Antimicrobial Agents and Chemotherapy ·Samir Ali,Vincent Lévêque,Sophie Le Pogam,Han Ma,(unknown),(unknown),Mark Smith,André Alker,Hyunsoon Kang,Isabel Nájera,Klaus Klumpp,Julian Symons,Nick Cammack,Wen-Rong Jiang	82
8	In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance 2006 ·Virology ·Sophie Le Pogam,Wen-Rong Jiang,Vincent Lévêque,Sonal Rajyaguru,Han Ma,Hyunsoon Kang,(unknown),(unknown),Samir Ali,Klaus Klumpp,(unknown),Julian Symons,Nick Cammack,Isabel Nájera	101
9	Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus 2006 ·Journal of Virology ·Sophie Le Pogam,Hyunsoon Kang,Seth F. Harris,Vincent Lévêque,Anthony M. Giannetti,Samir Ali,Wen-Rong Jiang,Sonal Rajyaguru,Gisele Tavares,Connie Oshiro,(unknown),Klaus Klumpp,Julian Symons,Michelle F. Browner,Nick Cammack,Isabel Nájera	103
10	The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture 2005 ·Journal of Biological Chemistry ·Klaus Klumpp,Vincent Lévêque,Sophie Le Pogam,Han Ma,Wen-Rong Jiang,Hyunsoon Kang,(unknown),(unknown),Carl Laxton,Julie Q. Hang,Keshab Sarma,David B. Smith,Dieter Heindl,Chris Hobbs,John H. Merrett,Julian Symons,Nick Cammack,Joseph A. Martin,René Devos,Isabel Nájera	166
11	Virus-Associated Nucleases: Location and Properties of Deoxyribonucleases and Ribonucleases in Purified Frog Virus 3 1972 ·Journal of Virology ·Hyunsoon Kang,B.R. McAuslan	32

About Hyunsoon Kang

Hyunsoon Kang is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 11 papers that have together received 795 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Hepatology (649 citations), Infectious Diseases (451 citations) and Virology (72 citations). Hyunsoon Kang has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Isabel Nájera, Sophie Le Pogam, Julian Symons, Nick Cammack, Wen-Rong Jiang, Sonal Rajyaguru, Samir Ali, Klaus Klumpp, Vincent Lévêque and Han Ma. Their work appears in journals such as Journal of Biological Chemistry, Journal of Virology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact